These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 10594530)

  • 1. Acute pancreatitis and parotitis induced by methimazole in a patient with Graves' disease.
    Taguchi M; Yokota M; Koyano H; Endo Y; Ozawa Y
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):667-70. PubMed ID: 10594530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute pancreatitis induced by methimazole in a patient with Graves' disease.
    Yang M; Qu H; Deng HC
    Thyroid; 2012 Jan; 22(1):94-6. PubMed ID: 22136208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methimazole-induced acute pancreatitis: a case report.
    Kikuchi I; Miyata N; Yoshimura Y; Miyamoto K; Tachikawa N
    Clin J Gastroenterol; 2019 Jun; 12(3):239-242. PubMed ID: 30474825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute pancreatitis induced by methimazole treatment in a 51-year-old korean man: a case report.
    Jung JH; Hahm JR; Jung J; Kim SK; Kim S; Kim KY; Kim BR; Kim HJ; Jeong YY; Kim SJ
    J Korean Med Sci; 2014 Aug; 29(8):1170-3. PubMed ID: 25120331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methimazole-induced agranulocytosis in patients with Graves' disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily.
    Takata K; Kubota S; Fukata S; Kudo T; Nishihara E; Ito M; Amino N; Miyauchi A
    Thyroid; 2009 Jun; 19(6):559-63. PubMed ID: 19445623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of antihistamines after serious allergic reaction to methimazole in pediatric Graves' disease.
    Toderian AB; Lawson ML
    Pediatrics; 2014 May; 133(5):e1401-4. PubMed ID: 24777217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Graves' hyperthyroidism with thionamides: a position paper on indications and safety in pregnancy.
    Tonacchera M; Chiovato L; Bartalena L; Cavaliere AF; Vitti P
    J Endocrinol Invest; 2020 Feb; 43(2):257-265. PubMed ID: 31784912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful Re-administration of Low-dose of Methimazole (MMI) in Graves' Disease Patients Who Experienced Allergic Cutaneous Reactions to MMI at Initial Treatment and Had Received Long-term Propylthiouracil (PTU).
    Kubota S
    Intern Med; 2016; 55(22):3235-3237. PubMed ID: 27853063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of Graves' hyperthyroidism with very long-term methimazole treatment: a clinical trial.
    Azizi F; Abdi H; Amouzegar A
    BMC Endocr Disord; 2021 Jan; 21(1):16. PubMed ID: 33446181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan.
    Yoshihara A; Noh JY; Watanabe N; Mukasa K; Ohye H; Suzuki M; Matsumoto M; Kunii Y; Suzuki N; Kameda T; Iwaku K; Kobayashi S; Sugino K; Ito K
    Thyroid; 2015 Oct; 25(10):1155-61. PubMed ID: 26222916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between methimazole and antineutrophil cytoplasmic antibody-positive vasculitis].
    Chen LQ; Zhang XL; Wu HY; Guo S; Li XZ
    Zhonghua Er Ke Za Zhi; 2008 Jun; 46(6):446-9. PubMed ID: 19099784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of efficacy and adverse effects between methimazole 15 mg+inorganic iodine 38 mg/day and methimazole 30 mg/day as initial therapy for Graves' disease patients with moderate to severe hyperthyroidism.
    Sato S; Noh JY; Sato S; Suzuki M; Yasuda S; Matsumoto M; Kunii Y; Mukasa K; Sugino K; Ito K; Nagataki S; Taniyama M
    Thyroid; 2015 Jan; 25(1):43-50. PubMed ID: 25178068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methimazole-induced aplastic anemia caused by hypocellular bone marrow with plasmacytosis.
    Yamamoto A; Katayama Y; Tomiyama K; Hosoai H; Hirata F; Kimura F; Fujita K; Yasuda H
    Thyroid; 2004 Mar; 14(3):231-5. PubMed ID: 15072706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very rare case of Graves' disease with resistance to methimazole: a case report and literature review.
    Mori Y; Hiromura M; Terasaki M; Kushima H; Ohara M; Fukui T; Takahashi Y; Yamagishi SI
    J Int Med Res; 2021 Mar; 49(3):300060521996192. PubMed ID: 33682498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relation of initial methimazole dose to the incidence of methimazole-induced agranulocytosis in patients with Graves' disease.
    Tsuboi K; Ueshiba H; Shimojo M; Ishikawa M; Watanabe N; Nagasawa K; Yuasa R; Yoshino G
    Endocr J; 2007 Feb; 54(1):39-43. PubMed ID: 17053291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothyroidism during antithyroid drug treatment with methimazole is a favorable prognostic indicator in patients with Graves' disease.
    Choo YK; Yoo WS; Kim DW; Chung HK
    Thyroid; 2010 Sep; 20(9):949-54. PubMed ID: 20629556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of perinuclear antineutrophil cytoplasmic antibody in patients with Graves' disease treated with propylthiouracil or methimazole in Taiwan.
    Huang CN; Hsu TC; Chou HH; Tsay GJ
    J Formos Med Assoc; 2004 Apr; 103(4):274-9. PubMed ID: 15175822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyarthritis caused by methimazole in two Japanese patients with graves' disease.
    Nihei H; Tada H; Naruse Y; Izawa M; Kato M; Okuno H; Nakamura A; Ishizu K; Hamajima T; Tajima T
    J Clin Res Pediatr Endocrinol; 2013; 5(4):270-2. PubMed ID: 24379039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation.
    Yoshihara A; Noh J; Yamaguchi T; Ohye H; Sato S; Sekiya K; Kosuga Y; Suzuki M; Matsumoto M; Kunii Y; Watanabe N; Mukasa K; Ito K; Ito K
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2396-403. PubMed ID: 22547422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.